283 related articles for article (PubMed ID: 25539273)
1. Periprostatic fat thickness on MRI: correlation with Gleason score in prostate cancer.
Woo S; Cho JY; Kim SY; Kim SH
AJR Am J Roentgenol; 2015 Jan; 204(1):W43-7. PubMed ID: 25539273
[TBL] [Abstract][Full Text] [Related]
2. The combination of prostate imaging reporting and data system version 2 (PI-RADS v2) and periprostatic fat thickness on multi-parametric MRI to predict the presence of prostate cancer.
Cao Y; Cao M; Chen Y; Yu W; Fan Y; Liu Q; Gao G; Zhao Z; Wang X; Jin J
Oncotarget; 2017 Jul; 8(27):44040-44049. PubMed ID: 28476042
[TBL] [Abstract][Full Text] [Related]
3. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
[TBL] [Abstract][Full Text] [Related]
4. PI-RADS v2 and periprostatic fat measured on multiparametric magnetic resonance imaging can predict upgrading in radical prostatectomy pathology amongst patients with biopsy Gleason score 3 + 3 prostate cancer.
Zhai L; Fan Y; Sun S; Wang H; Meng Y; Hu S; Wang X; Yu W; Jin J
Scand J Urol; 2018; 52(5-6):333-339. PubMed ID: 30895901
[TBL] [Abstract][Full Text] [Related]
5. Periprostatic fat thickness quantified by preoperative magnetic resonance imaging is an independent risk factor for upstaging from cT1/2 to pT3 in robot-assisted radical prostatectomy.
Iemura Y; Hori S; Tatsumi Y; Fukui S; Miyake M; Matsumura Y; Kagebayashi Y; Samma S; Fujimoto K
Int J Urol; 2020 Dec; 27(12):1144-1149. PubMed ID: 32969085
[TBL] [Abstract][Full Text] [Related]
6. Periprostatic Fat: A Risk Factor for Prostate Cancer?
Tan WP; Lin C; Chen M; Deane LA
Urology; 2016 Dec; 98():107-112. PubMed ID: 27592523
[TBL] [Abstract][Full Text] [Related]
7. [Influence of obesity on clinicopathological characteristics in patients with clinically localized prostate cancer].
Qu YY; Dai B; Chang K; Kong YY; Gu CY; Zhang GM; Wan FN; Wang HK; Zhang HL; Zhu Y; Ye DW
Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1089-93. PubMed ID: 24499718
[TBL] [Abstract][Full Text] [Related]
8. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
[TBL] [Abstract][Full Text] [Related]
9. Preoperative assessment of prostate cancer using prebiopsy MRI.
Min JH; Park BK; Park JJ; Park SY; Kim CK
AJR Am J Roentgenol; 2014 Aug; 203(2):341-6. PubMed ID: 25055269
[TBL] [Abstract][Full Text] [Related]
10. Periprostatic adiposity measured on magnetic resonance imaging correlates with prostate cancer aggressiveness.
Zhang Q; Sun LJ; Qi J; Yang ZG; Huang T; Huo RC
Urol J; 2014 Sep; 11(4):1793-9. PubMed ID: 25194078
[TBL] [Abstract][Full Text] [Related]
11. Pre-biopsy 3-Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot-assisted radical prostatectomy.
Patel U; Dasgupta P; Challacombe B; Cahill D; Brown C; Patel R; Kirby R
BJU Int; 2017 Jan; 119(1):82-90. PubMed ID: 27153933
[TBL] [Abstract][Full Text] [Related]
12. Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy.
Zhou M; Hayasaka S; Taylor JM; Shah R; Proverbs-Singh T; Manley S; Rubin MA
J Urol; 2001 Dec; 166(6):2193-7. PubMed ID: 11696734
[TBL] [Abstract][Full Text] [Related]
13. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
[TBL] [Abstract][Full Text] [Related]
14. Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology.
Boesen L; Chabanova E; Løgager V; Balslev I; Thomsen HS
J Magn Reson Imaging; 2015 Aug; 42(2):446-53. PubMed ID: 25408104
[TBL] [Abstract][Full Text] [Related]
15. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
[TBL] [Abstract][Full Text] [Related]
16. MRS measured fatty acid composition of periprostatic adipose tissue correlates with pathological measures of prostate cancer aggressiveness.
Iordanescu G; Brendler C; Crawford SE; Wyrwicz AM; Venkatasubramanian PN; Doll JA
J Magn Reson Imaging; 2015 Sep; 42(3):651-7. PubMed ID: 25522916
[TBL] [Abstract][Full Text] [Related]
17. Normalized periprostatic fat MRI measurements can predict prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localised disease.
Dahran N; Szewczyk-Bieda M; Wei C; Vinnicombe S; Nabi G
Sci Rep; 2017 Jul; 7(1):4630. PubMed ID: 28680067
[TBL] [Abstract][Full Text] [Related]
18. Prediction of extraprostatic cancer by prostate specific antigen density, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer.
Horiguchi A; Nakashima J; Horiguchi Y; Nakagawa K; Oya M; Ohigashi T; Marumo K; Murai M
Prostate; 2003 Jun; 56(1):23-9. PubMed ID: 12746843
[TBL] [Abstract][Full Text] [Related]
19. Periprostatic fat adipokine expression is correlated with prostate cancer aggressiveness in men undergoing radical prostatectomy for clinically localized disease.
Dahran N; Szewczyk-Bieda M; Vinnicombe S; Fleming S; Nabi G
BJU Int; 2019 Jun; 123(6):985-994. PubMed ID: 29969844
[TBL] [Abstract][Full Text] [Related]
20. Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.
Veltri RW; Miller MC; Mangold LA; O'Dowd GJ; Epstein JI; Partin AW
J Urol; 2002 Jul; 168(1):100-4. PubMed ID: 12050500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
